Again a great Friday Afternoon planned for 29 March 2019 about Clinical Trials.
Our upcoming Expert Class is organised in collaboration with Pivot Park Oss, 3D-PharmXchange, Xeltis and Amgen. Experts from these renowned organisations are willing to invest time to present their views to you. In addition there is time to discuss and make new connections.
We hope to welcome you (again) at the LS@W Expert Class. The programme starts at 12:00 hrs, lunch and ‘borrel’ are included. Download the programme >
Participation is again free for startups. Be there and realize how valuable these connections can be! Register here >
Ronald van der Geest, Managing Partner, 3D-PharmXchange
Jackie Droste, Manager, Radboud UMC Technology Center Clinical Studies Policy Quality and Support
Joep Rijnierse, Medical Director, Amgen/Board Member, HollandBio/Chairman Working Group Real Life Data, Vereniging Innovatieve Geneesmiddelen
Luc Verhees, Senior Vice President for Clinical, Pre-clinical and Medical Affairs, Xeltis
Rick Meurders, Business Developer, Pivot Park
Clinical Trials: Getting a clinical trial underway is no simple task. From patient recruitment to study completion, the drug maker or med tech developer must undertake a wide array of complex, and closely monitored operations, complying with regulations all the way. Trials become more global, patient groups more targeted, and investigator sites more widespread. Where to begin and how to set it up? Closely connected with Clinical Trials are Regulatory Affairs: The final hurdle – getting your drug, therapy or medical device approved and on the market. Talk with experts about the regulatory requirements in Europe and the rest of the world, since they are continually evolving and vary from one country to another. What does it take to navigating through the different regulatory landscapes?
About the L@SW Expert Classes
LS@W Expert Classes are a series of targeted workshops organized in close collaboration with industry experts on relevant topics for Life Sciences and Medical Technologies Startups. These small-scale Expert Classes are specially organized for alumni and participants of the Venture Challenge, Value Centre, MedtechPartners, BiotechPartner and Take off and are free of charge. Read more >>
Send an email to Ellen de Waal: firstname.lastname@example.org, adding the following details: First name – suffix -last name – email – phone and/or cell phone; Name of the startup – status startup – stage of your startup; Questions for the experts. Note: Startups not (yet) part of our LS@W community but who are interested to join are welcome provided you match our community profile.
We thank our 2017/2018/2019 contributing Experts from:
Loyens & Loeff, Progress EXS, YesDelft, Amsterdam UMC-University of Amsterdam, CbusineZ, Agendia, Sanofi, TU Delft/Delft Enterprises, NLO, European Patent and Trademark Attorneys, DSM Global Business Incubator, TU/E Innovation Lab, Usono, Philips, M Ventures, RVO, Merck Ventures, 2-BBB, Aglaia BioMedical Ventures, Netherlands Enterprise Agency (RVO), BioGeneration Ventures, Kite Pharma EU, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Axon, eNovITe, Thuja Capital, Technology Transfer Office, Erasmus MC, European Patent Office, InnovationQuarter, Luris, BioPartner Leiden, PSR Orphan Experts, Paul Janssen Futurelab Leiden, Utrecht Holding, MDxHealth, Julius Center THINC, UMC Utrecht, Vereniging Innovatieve Geneesmiddelen, UMotion, Sciences Affairs.